BackPlus Therapeutics Overview

Plus Therapeutics Total Liabilities

Track Plus Therapeutics's total liabilities ($8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$7.96M
77.72% YoYΔ $-27.74M vs prior year quarter

Peer average / median

Loading

Plus Therapeutics Total Liabilities History

Loading

Plus Therapeutics vs. peers: Total Liabilities Comparison

Loading

Plus Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Plus Therapeutics (PSTV) FAQ

As of the most recent data (March 2026), PSTV shows a total liabilities of $8M. That compares with $36M in the prior-year period — down 77.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PSTV's total liabilities is now $8M (was $36M) — a 77.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Plus Therapeutics is outperforming or lagging.

Tracking PSTV's total liabilities over time shows whether Plus Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $8M That compares with $36M in the prior-year period — down 77.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Plus Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $8M) with ownership activity and broader fundamentals.

Plus Therapeutics's total liabilities is $8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.